Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Novo Nordisk lowers 2025 guidance as Wegovy and Ozempic face slower U.S. uptake, competition, and continued compounded GLP-1 sales.

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...

New research reveals GLP-1 drugs like Ozempic may reduce stroke risk and improve recovery. At the 22nd Annual Meeting of the ...

Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.

In recent years, the popularity of weight-loss drugs like Ozempic and Wegovy has soared so dramatically that they’ve inspired new vocabulary, spurred global shortages, and prompted moral debates.

Studies presented at the Society of Neurointerventional Surgery’s show links between GLP-1s and the prevention of strokes and ...

Oprah Winfrey is hosting a sit-down conversation around the impact of prescription weight loss medications in the ABC primetime event, "An Oprah Special: Shame, Blame and the Weight Loss Revolution." ...

Ozempic and Mounjaro were approved by the FDA in 2017 and 2022, respectively, as treatments for Type 2 diabetes. In some cases, people are using the drugs off-label to lose weight.